Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan D Voss

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Journal of Pediatric Surgery|June 21, 2011
Adrenal cortical tumors in children: factors associated with poor outcomeJustin D Klein, Christopher G Turner, Fabienne L Gray, et al.
Pediatric Blood & Cancer|December 24, 2019
Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH)Jocelyn Lewis, Kathleen McCarten, Lars Kurch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.
Pediatric Blood & Cancer|April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology GroupMeredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Journal of Pediatric Surgery|March 15, 2019
Multicenter pre-operative assessment of pediatric ovarian malignancyArin L Madenci, Robert J Vandewalle, Bryan V Dieffenbach, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2024
Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary StatementJohn T Lucas, Zachary R Abramson, Katherine Epstein, et al.
Pediatric Blood & Cancer|September 27, 2014
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I ConsortiumStephan D Voss, Julia Glade-Bender, Sheri L Spunt, et al.
Bioconjugate Chemistry|February 27, 2015
The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistributionJason L J Dearling, Brett M Paterson, Vamsidhar Akurathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Pediatric Blood & Cancer|October 28, 2016
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology GroupCindy L Schwartz, Lu Chen, Kathleen McCarten, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Surgery|June 21, 2011
Adrenal cortical tumors in children: factors associated with poor outcomeJustin D Klein, Christopher G Turner, Fabienne L Gray, et al.
Pediatric Blood & Cancer|December 24, 2019
Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH)Jocelyn Lewis, Kathleen McCarten, Lars Kurch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.
Pediatric Blood & Cancer|April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology GroupMeredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Journal of Pediatric Surgery|March 15, 2019
Multicenter pre-operative assessment of pediatric ovarian malignancyArin L Madenci, Robert J Vandewalle, Bryan V Dieffenbach, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2024
Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary StatementJohn T Lucas, Zachary R Abramson, Katherine Epstein, et al.
Pediatric Blood & Cancer|September 27, 2014
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I ConsortiumStephan D Voss, Julia Glade-Bender, Sheri L Spunt, et al.
Bioconjugate Chemistry|February 27, 2015
The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistributionJason L J Dearling, Brett M Paterson, Vamsidhar Akurathi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Pediatric Blood & Cancer|October 28, 2016
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology GroupCindy L Schwartz, Lu Chen, Kathleen McCarten, et al.
Pageof 11